JoVE General
Alex H. Tuttle*, Matthew M. Rankin*, Monica Teta, Daniel J. Sartori, Geneva M. Stein, Gina J. Kim, Cristina Virgilio, Anne Granger, Di Zhou, Simon H. Long, Alisa B. Schiffman, Jake A. Kushner
Division of Endocrinology and Diabetes, Children’s Hospital of Philadelphia, Institute of Diabetes Obesity and Metabolism, Institute for Regenerative Medicine, Department of Pediatrics, University of Pennsylvania-School of Medicine
We hebben afgeleid van een strategie om sequentiële opname van thymidine-analogen (CldU en IDU) op te sporen in de weefsels van volwassen muizen om twee opeenvolgende rondes van celdeling te kwantificeren. Deze strategie is nuttig om de celvernieuwing van de langlevende weefsels, oncogene transformatie, of transit-amplificerende cellen te detecteren.
Diabetes. Jun, 2009 | Pubmed ID: 19336674
Heterozygous activating mutations of glucokinase have been reported to cause hypoglycemia attributable to hyperinsulinism in a limited number of families. We report three children with de novo glucokinase hyperinsulinism mutations who displayed a spectrum of clinical phenotypes corresponding to marked differences in enzyme kinetics.